238 related articles for article (PubMed ID: 16424394)
21. Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis.
Hos D; Bachmann B; Bock F; Onderka J; Cursiefen C
Exp Eye Res; 2008 Nov; 87(5):427-32. PubMed ID: 18755186
[TBL] [Abstract][Full Text] [Related]
22. Regulation of lymphangiogenesis in the diaphragm by macrophages and VEGFR-3 signaling.
Ochsenbein AM; Karaman S; Proulx ST; Goldmann R; Chittazhathu J; Dasargyri A; Chong C; Leroux JC; Stanley ER; Detmar M
Angiogenesis; 2016 Oct; 19(4):513-24. PubMed ID: 27464987
[TBL] [Abstract][Full Text] [Related]
23. Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?
Goyal S; Chauhan SK; El Annan J; Nallasamy N; Zhang Q; Dana R
Arch Ophthalmol; 2010 Jul; 128(7):819-24. PubMed ID: 20625040
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis.
Björndahl MA; Cao R; Burton JB; Brakenhielm E; Religa P; Galter D; Wu L; Cao Y
Cancer Res; 2005 Oct; 65(20):9261-8. PubMed ID: 16230387
[TBL] [Abstract][Full Text] [Related]
25. Involvement of hepatocyte growth factor in the development of bone metastasis of a mouse mammary cancer cell line, BALB/c-MC.
Ono K; Kamiya S; Akatsu T; Nakamura C; Li M; Amizuka N; Matsumoto K; Nakamura T; Kugai N; Wada S
Bone; 2006 Jul; 39(1):27-34. PubMed ID: 16459153
[TBL] [Abstract][Full Text] [Related]
26. Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor.
Zlot C; Ingle G; Hongo J; Yang S; Sheng Z; Schwall R; Paoni N; Wang F; Peale FV; Gerritsen ME
J Biol Chem; 2003 Nov; 278(48):47654-9. PubMed ID: 14500721
[TBL] [Abstract][Full Text] [Related]
27. Neuropilin-2 contributes to LPS-induced corneal inflammatory lymphangiogenesis.
Tang X; Sun J; Du L; Du H; Wang L; Mai J; Zhang F; Liu P
Exp Eye Res; 2016 Feb; 143():110-9. PubMed ID: 26500194
[TBL] [Abstract][Full Text] [Related]
28. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages.
Maruyama K; Ii M; Cursiefen C; Jackson DG; Keino H; Tomita M; Van Rooijen N; Takenaka H; D'Amore PA; Stein-Streilein J; Losordo DW; Streilein JW
J Clin Invest; 2005 Sep; 115(9):2363-72. PubMed ID: 16138190
[TBL] [Abstract][Full Text] [Related]
29. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.
Albuquerque RJ; Hayashi T; Cho WG; Kleinman ME; Dridi S; Takeda A; Baffi JZ; Yamada K; Kaneko H; Green MG; Chappell J; Wilting J; Weich HA; Yamagami S; Amano S; Mizuki N; Alexander JS; Peterson ML; Brekken RA; Hirashima M; Capoor S; Usui T; Ambati BK; Ambati J
Nat Med; 2009 Sep; 15(9):1023-30. PubMed ID: 19668192
[TBL] [Abstract][Full Text] [Related]
30. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous lymphatic vessel formation and regression in the murine cornea.
Zhang H; Hu X; Tse J; Tilahun F; Qiu M; Chen L
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):334-8. PubMed ID: 20739466
[TBL] [Abstract][Full Text] [Related]
32. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.
Kubo H; Cao R; Brakenhielm E; Mäkinen T; Cao Y; Alitalo K
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8868-73. PubMed ID: 12070340
[TBL] [Abstract][Full Text] [Related]
33. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
[TBL] [Abstract][Full Text] [Related]
34. Limited versus total epithelial debridement ocular surface injury: Live fluorescence imaging of hemangiogenesis and lymphangiogenesis in Prox1-GFP/Flk1::Myr-mCherry mice.
Chang JH; Putra I; Huang YH; Chang M; Han K; Zhong W; Gao X; Wang S; Dugas-Ford J; Nguyen T; Hong YK; Azar DT
Biochim Biophys Acta; 2016 Oct; 1860(10):2148-56. PubMed ID: 27233452
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1.
Hara Y; Torii R; Ueda S; Kurimoto E; Ueda E; Okura H; Tatano Y; Yagi H; Ohno Y; Tanaka T; Masuko K; Masuko T
Cancer Sci; 2018 Oct; 109(10):3171-3182. PubMed ID: 30058195
[TBL] [Abstract][Full Text] [Related]
36. [New insights into the molecular mechanisms of lymphangiogenesis and pathophysiology].
Hirakawa S
Yakugaku Zasshi; 2012; 132(2):211-4. PubMed ID: 22293702
[TBL] [Abstract][Full Text] [Related]
37. MT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis.
Wong HL; Jin G; Cao R; Zhang S; Cao Y; Zhou Z
Nat Commun; 2016 Mar; 7():10824. PubMed ID: 26926389
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer.
Qin T; Huang D; Liu Z; Zhang X; Jia Y; Xian CJ; Li K
Cancer Sci; 2018 Aug; 109(8):2469-2478. PubMed ID: 29890027
[TBL] [Abstract][Full Text] [Related]
39. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
Mattila MM; Ruohola JK; Karpanen T; Jackson DG; Alitalo K; Härkönen PL
Int J Cancer; 2002 Apr; 98(6):946-51. PubMed ID: 11948478
[TBL] [Abstract][Full Text] [Related]
40. Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling.
Cursiefen C; Ikeda S; Nishina PM; Smith RS; Ikeda A; Jackson D; Mo JS; Chen L; Dana MR; Pytowski B; Kruse FE; Streilein JW
Am J Pathol; 2005 May; 166(5):1367-77. PubMed ID: 15855638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
